SUNNYVALE, Calif. and STOCKHOLM , July 13, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare ®
RayStation® will be Extended to Include Treatment Planning for the TomoTherapy® and CyberKnife® Systems SUNNYVALE, Calif. , and STOCKHOLM , Oct. 5, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today that they
Siemens to Expand Distribution of CyberKnife Systems As Part of its Global Product Portfolio Accuray and Siemens to Create Long-Term Research and Development Relationship to Identify Potential New Technologies and Products SUNNYVALE, Calif., June 9, 2010 /PRNewswire via COMTEX/ --Accuray (Nasdaq:
Latest Collaboration with Leading Research Institution Continues Partnership in New Technology Development SUNNYVALE, Calif. , May 22, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and
MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
Milestone System to Handle Full Patient Load for New, Integrated Cancer Center in Scottsdale, Arizona SUNNYVALE, Calif. , May 22, 2014 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the installation of its 500 th TomoTherapy® System at the grand opening of Palo Verde Cancer
SUNNYVALE, Calif. , Sept. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Board of Directors has appointed Louis J. Lavigne, Jr. and Dennis L. Winger as members of the company's Board of Directors.
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform SUNNYVALE, Calif. , Oct. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a pioneer in the robotic stereotactic radiosurgery (SRS) field announced today a collaboration with
MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision ® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA).
MADISON, Wis. , Oct. 3, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the CNNC-Accuray joint venture Tomo ® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration (NMPA).
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
